RIBOXIN

Inosine

Composition: each tablet contains:

active substance:inosine – 200 mg.

Therapeutic indications

As a part of the complex therapy for various diseases: ischemic heart disease (myocardial infarction, coronary failure, cardiac rhythm disturbance); cardiomyopathy of various genesis, congenital and acquired heart diseases, rheumatic heart diseases, myocarditis, coronary atherosclerosis, pulmonary heart (right heart enlargement and expansion), dystrophic changes in the myocardium after hard physical exercises and previous infectious diseases or as a result of endocrine disorders; hepatic cirrhosis, acute and chronic hepatitis, alcohol- and drug product-induced liver injuries, fatty degeneration of liver, gastric and duodenal ulcer. Drug product poisoning; surgery on an isolated kidney (as a pharmacological protection drug product, when the blood circulation of an organ under operation is terminated temporarily).

	АТС code
	C01EB
	Pharmaceutical form
	film-coated tablets 200 mg
	Storage conditions
	Store in protected from moisture and light place at temperature below 25°C.